Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment (HTG753)Product type:GuidanceProgramme:HealthTech guidancePublished: 9 July 2025
Transperineal laser ablation for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG737)Product type:GuidanceProgramme:HealthTech guidancePublished: 8 January 2025
Transurethral water-jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG691)Product type:GuidanceProgramme:HealthTech guidancePublished: 14 September 2023
Botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention (HTG685)Product type:GuidanceProgramme:HealthTech guidancePublished: 28 June 2023
GreenLight XPS for treating benign prostatic hyperplasia (HTG650)Product type:GuidanceProgramme:HealthTech guidancePublished: 29 November 2022
Optilume for treating recurrent bulbar urethral strictures (HTG649)Product type:GuidanceProgramme:HealthTech guidancePublished: 29 November 2022
Prostatic urethral temporary implant insertion for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG639)Product type:GuidanceProgramme:HealthTech guidancePublished: 21 September 2022
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG578)Product type:GuidanceProgramme:HealthTech guidancePublished: 4 May 2021
The PLASMA system for transurethral resection and haemostasis of the prostate (HTG563)Product type:GuidanceProgramme:HealthTech guidancePublished: 6 January 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder (HTG554)Product type:GuidanceProgramme:HealthTech guidancePublished: 3 September 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG545)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 June 2020
Transurethral water vapour ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG482)Product type:GuidanceProgramme:HealthTech guidancePublished: 21 August 2018
Prostate artery embolisation for lower urinary tract symptoms caused by benign prostatic hyperplasia (HTG469)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 April 2018
Sacral nerve stimulation for idiopathic chronic non-obstructive urinary retention (HTG391)Product type:GuidanceProgramme:HealthTech guidancePublished: 25 November 2015
Insertion of prostatic urethral lift implants to treat lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG329)Product type:GuidanceProgramme:HealthTech guidancePublished: 23 January 2014